Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16908 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2023. Written by Thomas R Harcourt-Brown and 1 co-authors. Institution: Langford Vets, University of Bristol School of Veterinary Sciences, Bristol, UK. Major MEDLINE topics: Epilepsy, Vagus Nerve Stimulation, Dog Diseases. Cited 4 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
The long-term effect of implantable vagus nerve stimulators (VNS) on seizures has not been evaluated in epileptic dogs.
Objectives
Report seizure frequency in medication-resistant epileptic dogs before and after VNS implantation. Animals Twelve client-owned dogs with idiopathic epilepsy and >1 seizure day per 3 weeks despite 3 months of appropriate use of 2 antiseizure medications and seizure diaries maintained 6 months before and >12 months after VNS implantation.
Methods
Uncontrolled, open-label, before and after study. Mean monthly seizures and inter-seizure periods obtained from contemporaneous seizure diaries in the 6 months before implantation were compared with 0 to 6 months, 7 to 12 months, and subsequent 12-month periods after implantation. The number of dogs with >50% decrease in seizure frequency, >3 times increase in inter-ictal period interval, and seizure freedom for >3 months at the time of death or last follow-up were recorded.
Results
Five of 12 dogs were euthanized <12 months after implantation. All 7 remaining dogs showed >50% decrease in seizure frequency until last follow-up, starting at a median of 37 to 48 months after implantation (range, 0-6 to 61-72 months) and a >3-fold increase in mean inter-seizure interval starting a median of 25 to 36 months after implantation (range, 0-6 months to 49-60 months), 3/7 dogs were seizure-free at death or last follow-up. Conclusions and Clinical Importance Monthly seizure frequencies decreased and inter-seizure intervals increased in all dogs 2 to 3 years after VNS implantation, but a high proportion were euthanized before this time point. Prospective clinical trials are required to establish causality and the magnitude of this association.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Langford Vets, University of Bristol School of Veterinary Sciences, Bristol, UK.
- Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
ORCID profiles: Thomas R Harcourt-Brown
Cite
APA
Harcourt-Brown, T. R., & Carter, M. (2023). Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16908
Vancouver
Harcourt-Brown TR, Carter M. Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16908
BibTeX
@article{HarcourtBrown2023,
author = {Harcourt-Brown, Thomas R and Carter, Michael},
title = {Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16908}
}
EUVIMED